Onconova Therapeutics announces $3.4 million registered direct offering of common stock
Onconova announced it has entered into securities purchase agreements with certain institutional and accredited investors to purchase an aggregate of 2,136,193 shares of its common stock, at a purchase price of $1.60 per share in a registered direct offering for gross proceeds of $3.4 million. September 23, 2019